CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 203585Orig1s000

First Page		Document Content
Date: 2012-11-28 14:50:13 Orphan drugs Omacetaxine mepesuccinate Lactams Pharmacokinetics Chronic myelogenous leukemia Body surface area Birmingham Small Arms Company Nitrazepam Imatinib Pharmacology Pharmaceutical sciences Medicine		CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 203585Orig1s000 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 1,02 MB Share Document on Facebook

	FDA Review NDA[removed]Omapro™ (omacetaxine mepesuccinate) ODAC March 22, 2010 Amy McKee, M.D. DocID: GfBD - View Document
	Microsoft Word - ODAC briefing book 07JAN2010 FINAL DocID: GcWw - View Document
	Microsoft PowerPoint - 1 Core Introduction (CI) FINAL DocID: G22y - View Document
	ChemGenex Pharmaceuticals OMAPRO™ (omacetaxine mepesuccinate) ODAC Briefing Book Errata DocID: FzZu - View Document
	Microsoft Word - ODAC briefing book Errata #2 page 51 DocID: FnHN - View Document